Navigation Links
FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Date:8/28/2012

is important because it shows COURAGE and angiography alone are not enough.  FAME 2 demonstrates that when deciding between OMT and interventional therapy you need to know if there is ischemia.  This will help lead to the right therapy for the right patient," commented Scott Huennekens, President & CEO of Volcano Corporation. "With the FAME 2 data in hand, and a few moments in the cath lab to perform FFR, interventional cardiologists can confidently say to their patients that PCI is the right personalized approach for them, and have the FFR value to prove it. Having the data now published in the New England Journal is a testament to the hard work of the investigators and the quality of the study design and execution."

FAME 2 showed that patients receiving PCI with proven ischemia by FFR had 66% fewer primary endpoint events including death, MI and urgent vascularization's than those patients treated with medical therapy alone (percentage of patients who had a primary endpoint event: 4.3% in the PCI group and 12.7% in the medical-therapy group; hazard ratio with PCI, 0.32; 95% confidence interval [CI], 0.19 to 0.53; P<0.001). The Registry arm also showed that patients with a negative FFR suggesting absence of ischemia did very well being treated with just medical therapy and no further intervention (primary endpoint event rate of 3.0%).

"The evidence continues to mount that using the physiology or the functional evaluation of a lesion is better than relying on angiography alone," added Joe Burnett, Executive Vice President and Physiology Business Unit Leader for Volcano. "We are all striving to improve outcomes and control costs at the same time, which means we need to make every device count. Tools available today like FFR and IVUS provide objective evidence to help make those critical decisions. Angiography guided PCI is giving way to Functional PCI to assess, guide and document each patient's unique episode of care. This is why we a
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
2. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
3. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
4. New Data from Silences Atu027 Anticancer Trial Published at ASCO
5. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
6. 1st SynCardia Total Artificial Heart Implant Performed in New England
7. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
8. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
9. Elsevier Launches New Journal: Discourse, Context and Media
10. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
11. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced financial results for its first quarter ended ... months ended December 31, 2014, revenue was $1,336,685. Operating ... $229,820 or $0.02 per share.  Covalon,s ... am very pleased with the significant progress we have ...
(Date:2/27/2015)... 2015 ... kongestive Herzinsuffizienz (CHF) in seiner ersten klinischen ...   Die israelische Firma ... für Patienten mit kongestiver Herzinsuffizienz (CHF) entwickelt ... Finanzierungsvorhaben über 5 Mio. USD abgeschlossen hat. ...
(Date:2/27/2015)... , Feb. 27, 2015  Chiasma, Inc., a ... product for the orphan condition acromegaly, today announced the ... Participants in the financing included new investors Rock Springs ... public investment fund, as well as existing investors MPM ... ARCH Venture Partners. Chiasma intends to ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
... recent study conducted by oculoplastic surgeon Charles Soparkar, ... a patent-pending formulation of zinc and phytase (trademarked ... oral administration for 4 days prior to a ... duration in 41 of 44 patients tested (93%). ...
... ABT ) announced today it has received approval from the U.S. ... e HBV assay for measuring viral load or the amount of ... first and only approved test capable of automating HBV viral load ... Abbott RealTi m e HBV assay, based on real-time PCR (polymerase ...
Cached Medicine Technology:Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 2Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 3Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 4
(Date:2/28/2015)... 28, 2015 The Heart Fit Clinic ... distributor of the machine. The Heart Fit Clinic is ... like a franchise model. The goal is to scale ... heart disease. To buy External Counterpulsation machines ... help individuals through this process and achieve the desired ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate ... provide business consulting services in addition to a variety ... and succession planning. Company finances are a complicated matter ... top of this, complex Canadian tax laws can make ... a result, Mew and Company works to advise their ...
(Date:2/28/2015)... A study out of the University ... procedure for the treatment of a hereditary ocular condition ... Authored by Dr. Robert MacLaren, professor of ophthalmology at ... Medical Journal on January 16, 2014 , the study ... disorder that mostly affects men and leads to the ...
(Date:2/28/2015)... Portland, OR (PRWEB) February 28, 2015 ... at the 2015 Japan Architecture & Construction Materials Show, ... They’ll join more than 1,000 suppliers and top manufacturers ... , Reclaimed wood products sourced and manufactured ... facilities have found popularity in Japan at restaurants, hotels, ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
Breaking Medicine News(10 mins):Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
... Founder of ... who accelerated her recovery. Lack of friends connected to poorer health Company aims to reduce ... ... The Friendship Stone will mark Friendship Week starting August 2nd. Founder, Cathy Raff, will dedicate ...
... , , New Report Is ... Lower Costs , , KANSAS CITY, Mo., ... marks for communicating effectively and treating them respectfully, according to a new patient experience ... 700 doctors are available at http://kcq i c.org ...
... , , OLYMPIA, ... prescription medications since the launch of the free statewide prescription assistance program. ... was launched in August, 2008. The program has no restrictions to membership, ... fill out. Anyone interested in receiving a free card can visit ...
... , , WARSAW, Ind., July ... independent provider of products to the global orthopaedic device industry and other ... results for the period ending July 4, 2009 before the market opens ... call at 8:00 a.m. ET on Thursday, August 6, 2009. , ...
... , , HOUSTON, July 21 US Oncology, ... on Thursday, August 6, 2009. , , A ... ET following distribution of the earnings release. Additional information will be available on ... on the day of the earnings announcement. , , ...
... IHA Completes the Second Chapter of the ... for Measurement Years 2006 - 2009 , ... (IHA) is pleased to announce the publication of "The Second Chapter," a ... for performance (P4P) program - the largest non-governmental physician incentive program in ...
Cached Medicine News:Health News:The Friendship Stone Helps Friends Remain Healthy 2Health News:The Friendship Stone Helps Friends Remain Healthy 3Health News:The Friendship Stone Helps Friends Remain Healthy 4Health News:Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 2Health News:Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 3Health News:Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 4Health News:Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind 5Health News:Free Drug Card Has Saved Washington Residents $2.6 Million 2Health News:Symmetry Medical to Report Second Quarter 2009 Financial Results on August 6, 2009 2Health News:US Oncology to Report 2009 Second Quarter Operating Results 2Health News:Integrated Healthcare Association Releases White Paper on Pay for Performance 2
Used with Single Tantalum Clip (E5381 854) and Double Tantalum Clip (E5381 853). Overall length: 7.2 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
2 mm x 0.75 mm. Overall length: 125 mm, 4.9 inches....
...
Medicine Products: